Cite
HARVARD Citation
Thompson, J. et al. (2021). Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy. JCO precision oncology. p. . [Online].